Arkolith/Insider Trading/NAUT/Form 4

Godwin Mary E.

Senior VP, OperationsNautilus Biotechnology, Inc. (NAUT) · full profile →Form 4 · filed Sep 18, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$100K
Net Open-Market Flow
-$100K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 17, 2024Sell(S)35K$2.85$100K0
Sep 17, 2024Option exercise(M)35K$0.46$16K35K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 17, 2024Option exercise(M)35K—$0400K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001808805-24-000065) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML